Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Tamura

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Anticancer Research|April 4, 2021
Efficacy of Ramucirumab <i>Versus</i> Sorafenib as Subsequent Treatment for Hepatocellular CarcinomaKazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 21, 2019
Hepatocellular carcinoma occurrence does not differ between interferon-based and interferon-free treatment with liver histological assessmentYuki Tahata, Ryotaro Sakamori, Ayako Urabe, et al.
Biochemical and Biophysical Research Communications|November 18, 2008
Delayed liver regeneration after partial hepatectomy in adiponectin knockout miceHisao Ezaki, Yuichi Yoshida, Yukiko Saji, et al.
Journal of Cellular Physiology|February 6, 2008
The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cellsYoko Murayama, Yasuhisa Shinomura, Kenji Oritani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[Clinical evaluation of the risk factors for liver abscess after TACE or RFA]Satoshi Oshima, Naoko Tani, Kenji Takaishi, et al.
Plos One|June 17, 2020
Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infectionNaoki Morishita, Ryotaro Sakamori, Tomomi Yamada, et al.
Gastroenterology|March 4, 2003
Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomyShinichi Kiso, Sumio Kawata, Shinji Tamura, et al.
Gastroenterology|January 16, 2004
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectinYoshihiro Kamada, Shinji Tamura, Shinichi Kiso, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 24, 2007
Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis CNaoki Hiramatsu, Nao Kurashige, Tsugiko Oze, et al.
Annals of Internal Medicine|June 4, 2008
Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003Hideo Tanaka, Yasuharu Imai, Naoki Hiramatsu, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Anticancer Research|April 4, 2021
Efficacy of Ramucirumab <i>Versus</i> Sorafenib as Subsequent Treatment for Hepatocellular CarcinomaKazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 21, 2019
Hepatocellular carcinoma occurrence does not differ between interferon-based and interferon-free treatment with liver histological assessmentYuki Tahata, Ryotaro Sakamori, Ayako Urabe, et al.
Biochemical and Biophysical Research Communications|November 18, 2008
Delayed liver regeneration after partial hepatectomy in adiponectin knockout miceHisao Ezaki, Yuichi Yoshida, Yukiko Saji, et al.
Journal of Cellular Physiology|February 6, 2008
The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cellsYoko Murayama, Yasuhisa Shinomura, Kenji Oritani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[Clinical evaluation of the risk factors for liver abscess after TACE or RFA]Satoshi Oshima, Naoko Tani, Kenji Takaishi, et al.
Plos One|June 17, 2020
Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infectionNaoki Morishita, Ryotaro Sakamori, Tomomi Yamada, et al.
Gastroenterology|March 4, 2003
Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomyShinichi Kiso, Sumio Kawata, Shinji Tamura, et al.
Gastroenterology|January 16, 2004
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectinYoshihiro Kamada, Shinji Tamura, Shinichi Kiso, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 24, 2007
Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis CNaoki Hiramatsu, Nao Kurashige, Tsugiko Oze, et al.
Annals of Internal Medicine|June 4, 2008
Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003Hideo Tanaka, Yasuharu Imai, Naoki Hiramatsu, et al.
Pageof 10